Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Ting-jie Guo"'
Rising evidence has shown the development of resistance to vascular endothelial growth factor receptor (VEGFR) inhibitors in the practices of cancer therapy. It is reported that the efficacy of axitinib (AX), a VEGFR inhibitor, is limited in the trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b53d53aabdda1365f71f01006b832706
https://europepmc.org/articles/PMC6329750/
https://europepmc.org/articles/PMC6329750/
